Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
Titel:
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
Auteur:
Zander, A.R. Schmoor, C. Kröger, N. Krüger, W. Möbus, V. Frickhofen, N. Metzner, B. Berdel, W.E. Koenigsmann, M. Thiel, E. Wandt, H. Possinger, K. Kreienberg, R. Schumacher, M. Jonat, W.